Notice of Intent To Grant An Exclusive License, 15263 [E6-4326]

Download as PDF Federal Register / Vol. 71, No. 58 / Monday, March 27, 2006 / Notices The agenda will include the following: Various IRS issues. Dated: March 21, 2006. John Fay, Acting Director, Taxpayer Advocacy Panel. [FR Doc. E6–4331 Filed 3–24–06; 8:45 am] BILLING CODE 4830–01–P DEPARTMENT OF THE TREASURY Internal Revenue Service Open Meeting of the Earned Income Tax Credit Committee of the Taxpayer Advocacy Panel Internal Revenue Service (IRS), Treasury. ACTION: Notice. AGENCY: An open meeting of the Earned Income Tax Credit Committee of the Taxpayer Advocacy Panel will be conducted at the Internal Revenue Service, 1111 Constitution Avenue, NW., Washington, DC 20224, in Room 7718. The Committee will be discussing issues pertaining to the IRS administration of the Earned Income Tax Credit. DATES: The meeting will be held Friday, April 21, 2006, from 9 a.m. through 12 noon ET. FOR FURTHER INFORMATION CONTACT: Audrey Y. Jenkins at 1–888–912–1227 (toll-free), or 718–488–2085 (non tollfree). SUMMARY: Notice is hereby given pursuant to Section 10(a) (2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) that an open meeting of the Earned Income Tax Credit Committee of the Taxpayer wwhite on PROD1PC65 with NOTICES SUPPLEMENTARY INFORMATION: VerDate Aug<31>2005 20:32 Mar 24, 2006 Jkt 208001 Advocacy Panel will be held Friday, April 21, 2006 from 9 a.m. to 12 p.m. ET at 1111 Constitution Avenue, NW., Washington, DC 20224, Room 7718. The public is invited to make oral comments. Individual comments will be limited to 5 minutes. For information or to confirm attendance, contact Audrey Y. Jenkins as noted above. Notification of intent to participate in the meeting must be made with Ms. Jenkins. If you would like a written statement to be considered, send written comments to Ms. Audrey Y. Jenkins, TAP Office, 10 MetroTech Center, 625 Fulton Street, Brooklyn, NY 11201 or post your comments to the Web site: https:// www.improveirs.org. The agenda will include various IRS issues. Dated: March 21, 2006. John Fay, Acting Director, Taxpayer Advocacy Panel. [FR Doc. E6–4341 Filed 3–24–06; 8:45 am] BILLING CODE 4830–01–P DEPARTMENT OF VETERANS AFFAIRS Notice of Intent To Grant An Exclusive License Office of Research and Development, Department of Veterans Affairs. ACTION: Notice of intent. AGENCY: SUMMARY: Notice is hereby given that the Department of Veterans Affairs, Office of Research and Development, intends to grant to New England Compounding Pharmacy, Inc., 697 Waverly Street, Framingham, MA 01701 an exclusive license to practice U.S. Patent No. 6,569,615 issued, May 27, PO 00000 Frm 00107 Fmt 4703 Sfmt 4703 15263 2003, entitled, ‘‘Compositions and Methods for Tissue Preservation.’’ DATES: Comments must be received by April 11, 2006. ADDRESSES: Send comments to: Amy E. Centanni, Director of Technology Transfer, Department of Veterans Affairs; Office of Research and Development Attn: 12TT; 810 Vermont Avenue, NW., Washington, DC 20420. Telephone: (202) 254–0199; Facsimile: (202) 254–0473; e-mail: amy.centanni@mail.va.gov. FOR FURTHER INFORMATION CONTACT: Copies of the published patent may be obtained from the U.S. Patent and Trademark Office at https:// www.uspto.gov. It is in the public interest to license this invention as New England Compounding Pharmacy, Inc., submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within fifteen (15) days from the date of this published Notice, the Department of Veterans Affairs, Office of Research and Development receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. SUPPLEMENTARY INFORMATION: Approved: March 17, 2006. Gordon H. Mansfield, Deputy Secretary of Veterans Affairs. [FR Doc. E6–4326 Filed 3–24–06; 8:45 am] BILLING CODE 8320–01–P \\ALPHA3\E\FR\FM\27MRN1.SGM 27MRN1

Agencies

[Federal Register Volume 71, Number 58 (Monday, March 27, 2006)]
[Notices]
[Page 15263]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-4326]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Notice of Intent To Grant An Exclusive License

AGENCY: Office of Research and Development, Department of Veterans 
Affairs.

ACTION: Notice of intent.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Department of Veterans 
Affairs, Office of Research and Development, intends to grant to New 
England Compounding Pharmacy, Inc., 697 Waverly Street, Framingham, MA 
01701 an exclusive license to practice U.S. Patent No. 6,569,615 
issued, May 27, 2003, entitled, ``Compositions and Methods for Tissue 
Preservation.''

DATES: Comments must be received by April 11, 2006.

ADDRESSES: Send comments to: Amy E. Centanni, Director of Technology 
Transfer, Department of Veterans Affairs; Office of Research and 
Development Attn: 12TT; 810 Vermont Avenue, NW., Washington, DC 20420. 
Telephone: (202) 254-0199; Facsimile: (202) 254-0473; e-mail: 
amy.centanni@mail.va.gov.

FOR FURTHER INFORMATION CONTACT: Copies of the published patent may be 
obtained from the U.S. Patent and Trademark Office at https://
www.uspto.gov.

SUPPLEMENTARY INFORMATION: It is in the public interest to license this 
invention as New England Compounding Pharmacy, Inc., submitted a 
complete and sufficient application for a license. The prospective 
exclusive license will be royalty-bearing and will comply with the 
terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective 
exclusive license may be granted unless, within fifteen (15) days from 
the date of this published Notice, the Department of Veterans Affairs, 
Office of Research and Development receives written evidence and 
argument which establishes that the grant of the license would not be 
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.

    Approved: March 17, 2006.
Gordon H. Mansfield,
Deputy Secretary of Veterans Affairs.
[FR Doc. E6-4326 Filed 3-24-06; 8:45 am]
BILLING CODE 8320-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.